NSTG - ナノストリング・テクノロジ―ズ (NanoString Technologies Inc.) ナノストリング・テクノロジ―ズ



symbol NSTG
会社名 NanoString Technologies Inc (ナノストリング・テクノロジ―ズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ナノストリング・テクノロジーズ(NanoString Technologies Inc.)は微量の組織から実用的なゲノム情報を科学的・臨床的に解き明かす製品の設計・製作・販売に従事する。同社は、単一の組織サンプルから数百の遺伝子およびタンパク質の活性を同時にプロファイリングするための機器、消耗品およびサービスの開発、製造および販売に従事する。同社のnCounter Analysis Systemはバーコード技術を使用して数百分子の分子を直接プロファイリングする自動化されたマルチアプリケーション、デジタル検出およびカウントシステムである。同社は基本的な生物学およびがんのような疾患の分子基盤、および診断用の臨床検査機関および医療センターに使用するためにシステムおよび関連消耗品を学術、政府および生物医薬品研究所の研究者に販売する。   ナノストリング・テクノロジ―ズは、米国の医療機器メ―カ―。ダイレクトデジタル計測遺伝子解析システム「nCounter」を開発、製造、販売する。バ―コ―ド技術により、最大800遺伝子を1チュ―ブで同時カウントする「nCounter」と関連する消耗品を学術、政府の研究者や臨床検査室、医療センタ―へ販売する。   NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 4,000 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx® Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.
本社所在地 530 Fairview Avenue North Seattle WA 98109 USA
代表者氏名 William D. Young ウィリアム・D・ヤング
代表者役職名 Independent Chairman of the Board
電話番号 +1 206-378-6266
設立年月日 37773
市場名 NASDAQ National Market System
ipoyear 2013年
従業員数 467人
url www.nanostring.com
nasdaq_url https://www.nasdaq.com/symbol/nstg
EBITDA EBITDA(百万ドル) -50.37300
終値(lastsale) 15.61
時価総額(marketcap) 464987745.32
時価総額 時価総額(百万ドル) 471.83890
売上高 売上高(百万ドル) 110.33300
企業価値(EV) 企業価値(EV)(百万ドル) 470.87190
当期純利益 当期純利益(百万ドル) -22.26800
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 NanoString Technologies Inc revenues decreased 9% to $48.1M. Net loss increased 70% to $39.8M. Revenues reflect North America segment decrease of 17% to $32.8M Asia Pacific segment decrease of 10% to $3.1M. Higher net loss reflects Research and development increase of 30% to $28.4M (expense) Selling general and administrative increase of 11% to $40.1M (expense).



   Spatial Genomics and Transcriptomics Market worth $404 million by 2025 - Leading Key Players are 10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US)  2021/09/09 14:56:35 OpenPR
According to the new market research report "Spatial Genomics and Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Drug Discovery),End User (Academic Institute, Research Institutes, CROs)-Global Forecast to 2025", published by MarketsandMarkets, the Global Spatial
   NanoString to Webcast Presentation from the 19th Annual Morgan Stanley Global Healthcare Conference  2021/09/01 20:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString to present at Morgan Stanley Global Healthcare Conference.
   NanoStrings GeoMx Digital Spatial Profiling Platform Reveals Insights Into the Immune Landscape of Cancer in Publication in the Journal Cell  2021/08/31 10:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString announced a peer-reviewed publication using the GeoMx® Digital Spatial Profiler (DSP), published in the journal Cell.
   Global Breast Cancer Diagnostics Market to grow with a Healthy CAGR, Forecast 2020 2027 | Key Players Genomic Health., Myriad Genetics, Inc., NanoString Technologies, Inc., Hologic, Inc., Koninklijke Philips N.V.  2021/08/09 18:32:20 OpenPR
Global Breast Cancer Diagnostics Market research document has been prepared by considering several fragments of the present and upcoming market scenario. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics,
   Global Spatial Genomics & Transcriptomics Market 2021 Growth Factors, Technological Innovation and Emerging Trends 2027 | NanoString Technologies, Seven Bridges Genomic, Horizon Discovery Group  2021/08/05 13:48:43 OpenPR
The phrase spatial transcriptomics" refers to a group of techniques for assigning cell types to precise locations in histological sections. The approach can also be used to determine mRNA molecule subcellular localisation. Researchers can uncover and investigate cellular heterogeneity in
   Circulating Tumor Cells Market Future Prospects 2026: IV Diagnostics, Vitatex, Nanostring Technologies  2021/07/10 21:41:50 Tramways Monthly
The Global Circulating Tumor Cells Market report sheds light on noteworthy industry trends, emerging issues and key areas of opportunity that help Circulating Tumor Cells manufacturers decide top strategic priorities in next few years. The executive outlook presented in Circulating Tumor Cells research reflects the overall industry, with respondents surveyed from different geographies, company sizes, and industry []
   NanoString to Release Second Quarter 2021 Operating Results and Host Conference Call on Wednesday, August 4, 2021  2021/07/08 10:00:00 Finanzen AT
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release second quarter 2021 operating results after the
   NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy  2021/06/22 10:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® Stem Cell Characterization Panel for the analysis and optimization of stem cell lines used in the development of potential novel therapeutics. Recent breakthroughs in stem cell therapy, regenerative medicine, and CRISPR engineering have advanced the development of promising new treatments for debili
   NanoString: Compelling Upside For This Spatial Biology Instrument Developer  2021/06/17 16:15:23 Seeking Alpha
   NanoString forms alliance to optimize cell therapies in cancer  2021/06/15 10:19:18 Seeking Alpha
   NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference  2021/03/01 15:06:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString announces highlights of 2021 Advances in Genome Biology and Technology conference.
   NanoString Technologies Earnings Report: Here’s what to expect from Stock market Insights & financial analysis  2021/03/01 14:10:00 Stock Market Daily
NanoString Technologies announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   A Preview Of NanoString Technologies's Earnings  2021/02/26 10:06:00 Benzinga
NanoString Technologies (NASDAQ:NSTG) unveils its next round of earnings this Monday, March 01. Get prepared with Benzinga's ultimate preview for …
   NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference  2021/02/24 11:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString to present at the 41st annual Cowen healthcare conference.
   NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021  2021/02/22 11:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString announces launch of GeoMx DSP Whole Transcriptome Atlas.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ナノストリング・テクノロジ―ズ NSTG NanoString Technologies Inc.)


 twitter  (公式ツイッターやCEOツイッターなど)